The US Food and Drug Administration has hidden from the public problems with clinical trials, including instances of scientific fraud, according to an article published in JAMA Internal Medicine.

In the article, Charles Seife, who teaches journalism at New York University, looked at 78 publications on trials in which the FDA found serious issues, and determined that only three of the publications had any mention of the problems uncovered by the agency.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.